What is Fortis Healthcare Ltd (FORTIS) share price today?

Fortis Healthcare Ltd (FORTIS) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/FORTIS for the latest live price, technical analysis, and AI-powered insights.

How to analyse FORTIS stock?

VestAI provides comprehensive FORTIS stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Fortis Healthcare Ltd in?

Fortis Healthcare Ltd (FORTIS) is in the Healthcare sector, Hospital industry on the NSE.

Fortis Healthcare Ltd

Name: Fortis Healthcare Ltd (FORTIS) Financial Metrics
Creator: VestAI

FORTIS

NSE· Healthcare

₹952.45

-10.65 (-1.11%)

Updated 11:26 am IST

52W Low · ₹766.8052W High · ₹1,104.30

Mid Range

Market Cap

₹73129.02L Cr

Volume

6.05L

Prev Close

₹963.10

ISIN

INE061F01013

Orion Score

Fundamentals-based quality & risk · not a recommendation

55/100

Watch

Fortis Healthcare Ltd scores 55/100 (Watch) on the Orion Score — moderate business quality (62), moderate growth (66), moderate balance-sheet safety (62) and rich valuation (13). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.5× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(5.09)Beneish M Clean(-2.39)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

58/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.34x — lean balance sheet

QUALITY

Average

ROCE 11.8% — decent returns

MOMENTUM

Neutral

RSI 48.0 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 70.45
ROCE: 11.81%
ROE (1Y): 11.01%
D/E Ratio: 0.34x
OPM: 17.35%
TTM EPS: ₹13.75
Dividend Yield: 10.00%
Qtrly Sales: ₹2,364.67 Cr
Qtrly Profit: ₹265.85 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹2,364.67	₹265.85	17.4%	₹3.52
Q3 2026	₹2,265.01	₹193.73	17.0%	₹2.57
Q2 2026	₹2,331.44	₹321.92	19.3%	₹4.26
Q1 2026	₹2,166.72	₹260.28	18.0%	₹3.45
Q4 2025	₹2,007.2	₹183.89	16.6%	₹2.44

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹9,127.84	₹1,041.78	₹2,129.75	17.9%
FY 2025	₹7,782.75	₹774.21	₹1,577.06	15.4%
FY 2024	₹6,835.09	₹598.88	₹1,308.51	13.3%
FY 2023	₹6,213.15	₹588.73	₹1,237.8	12.4%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
FORTIS ★	₹73,129 Cr	70.45	11.81%	11.01%	0.34x	17.35%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹13,691.53	₹13,288.78	₹12,433.6	₹11,884.75
Equity	₹8,916.52	₹7,662.9	₹7,242.26	₹6,178.24
Total Debt	₹2,475.11	₹1,155.02	₹925.72	₹1,254.93
Cash	₹139.72	₹235.27	₹141.08	₹143.23
Net Debt	₹2,055.59	₹623.03	₹562.07	₹822.44
Working Capital	₹-135.95	₹-1,749.58	₹-19.53	₹-136.17

Shareholding Pattern

Q1 FY2027

Promoter

35.19%

FII

26.57%

DII

21.74%

Public

16.5%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	35.19%	26.57% ↓	21.74% ↓	16.5% ↑
Q4 FY2026	35.19% ↑	27.65% ↓	22.63% ↓	14.53% ↑
Q3 FY2026	31.17%	27.84% ↓	29.33% ↑	11.65% ↓
Q2 FY2026	31.17%	27.9% ↑	29.14% ↓	11.79% ↓
Q1 FY2026	31.17%	27.18% ↓	29.79% ↑	11.87% ↓
Q4 FY2025	31.17%	27.4% ↑	29.46% ↓	11.98% ↓
Q3 FY2025	31.17%	26.77% ↑	30.05% ↓	12.02% ↓
Q2 FY2025	31.17%	25.26%	30.73%	12.83%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

239 mutual fund schemes

Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct GrowthMOTILAL_OSWAL

8.05%

₹3 Cr

Tata Nifty MidSmall Healthcare Index Fund Direct GrowthTATA

8.05%

₹14 Cr

Motilal Oswal Nifty MidSmall India Consumption Index Fund Direct GrowthMOTILAL_OSWAL

5.64%

₹1 Cr

Axis Services Opportunities Fund Direct GrowthAXIS

4.76%

₹75 Cr

DSP Nifty Healthcare Index Fund Direct GrowthDSP

4.64%

₹1 Cr

LIC MF Healthcare Fund Direct GrowthLIC

4.49%

₹4 Cr

Kotak Healthcare Fund Direct GrowthKOTAK_MAHINDRA

4.31%

₹24 Cr

Baroda BNP Paribas Health and Wellness Fund Direct GrowthBARODABNPPARIBASMUTUALFUND_MF

4.27%

₹23 Cr

Nippon India MNC Fund Direct GrowthRELIANCE

4.24%

₹18 Cr

Arthaya Equity Long Short Fund Direct GrowthARTHAYA

4.19%

—

Analyse FORTIS with Orion AI

Ask: "Is Fortis Healthcare Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Fortis Healthcare Ltd (FORTIS) Stock

Fortis Healthcare Ltd is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE061F01013. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.